| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1998PNAS...95.7574A |
| P356 | DOI | 10.1073/PNAS.95.13.7574 |
| P932 | PMC publication ID | 22687 |
| P698 | PubMed publication ID | 9636191 |
| P5875 | ResearchGate publication ID | 235614897 |
| P50 | author | Bettina Hansen | Q40007319 |
| Bjarke E Hansen | Q57415263 | ||
| P2093 | author name string | H Jacobsen | |
| R Holmdahl | |||
| J Engberg | |||
| J B Rothbard | |||
| L Fugger | |||
| A Svejgaard | |||
| C B Andersen | |||
| V Malmström | |||
| L S Madsen | |||
| E C Andersson | |||
| G S McDevitt | |||
| P2860 | cites work | Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide | Q27731272 |
| Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 | Q27733853 | ||
| X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II | Q27746792 | ||
| The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis | Q28306666 | ||
| Associations between HLA and antibodies to collagen in rheumatoid arthritis | Q33562837 | ||
| Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis | Q33832421 | ||
| Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression | Q34400802 | ||
| Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response | Q35557064 | ||
| T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire | Q36230696 | ||
| Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101,beta1*0401) transgenic mice. | Q36301274 | ||
| Autoimmunity to type II collagen an experimental model of arthritis | Q36335891 | ||
| Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association | Q36364795 | ||
| HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis | Q36366088 | ||
| An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. | Q36377027 | ||
| A mechanism for the major histocompatibility complex-linked resistance to autoimmunity | Q36380664 | ||
| The HLA-DQ7 and -DQ8 associations in DR4-positive rheumatoid arthritis patients. A combined analysis of data available in the literature | Q36894144 | ||
| Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis | Q37702346 | ||
| Type II collagen autoimmunity in animals and provocations leading to arthritis | Q37783217 | ||
| MHC ligands and peptide motifs: first listing | Q40612811 | ||
| Functional characterization of HLA-DRA1*0101/DRB1*0401 molecules expressed in Drosophila melanogaster cells | Q41057414 | ||
| Characterization of the T cell receptor repertoire causing collagen arthritis in mice | Q41859484 | ||
| CDR3 length in antigen-specific immune receptors | Q41875752 | ||
| T cell recognition of carbohydrates on type II collagen | Q41897916 | ||
| Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen. | Q52307926 | ||
| Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. | Q52481758 | ||
| Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen. | Q54434543 | ||
| Local anti—type ii collagen antibody production in rheumatoid arthritis synovial fluid | Q57351538 | ||
| Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis | Q57351990 | ||
| Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen | Q57352355 | ||
| Immunisation against heterologous type II collagen induces arthritis in mice | Q59053172 | ||
| Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis | Q70080495 | ||
| Rheumatoid arthritis | Q71046923 | ||
| Could HLA-DRB1 be the protective locus in rheumatoid arthritis? | Q71708457 | ||
| Prediction of peptide affinity to HLA DRB1*0401 | Q72240111 | ||
| IgG and IgM antibody to native type II collagen in rheumatoid arthritis serum and synovial fluid. Evidence for the presence of collagen-anticollagen immune complexes in synovial fluid | Q72405031 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 7574-7579 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice | |
| P478 | volume | 95 |
| Q42845041 | A triple altered collagen II peptide with consecutive substitutions of TCR contacting residues inhibits collagen-induced arthritis |
| Q73313513 | Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis |
| Q37382486 | Antigen-specific gene therapy after immunisation reduces the severity of collagen-induced arthritis. |
| Q42796924 | Association Analysis about HLA-DRB1, -DQB1 Polymorphism and Auto-Antibodies Against α1-Adrenergic Receptors in Chinese Patients with Essential Hypertension |
| Q24807019 | Association of MHC and rheumatoid arthritis. HLA-DR4 and rheumatoid arthritis: studies in mice and men |
| Q44967035 | Citrullination of self-proteins and autoimmunity |
| Q36907623 | Comparative analysis of collagen type II-specific immune responses during development of collagen-induced arthritis in two B10 mouse strains. |
| Q55050150 | Complement in the Initiation and Evolution of Rheumatoid Arthritis. |
| Q54074839 | Complementation between HLA-DR4 (DRB1*0401) and specific H2-A molecule in transgenic mice leads to collagen-induced arthritis. |
| Q28741917 | Design of glycopeptides used to investigate class II MHC binding and T-cell responses associated with autoimmune arthritis |
| Q24807250 | Differential clinical efficacy of anti-CD4 monoclonal antibodies in rat adjuvant arthritis is paralleled by differential influence on NF-kappaB binding activity and TNF-alpha secretion of T cells |
| Q30978132 | Dissection of the genetic complexity of arthritis using animal models |
| Q37401753 | Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells. |
| Q51063598 | Facile synthesis of 5-hydroxy-L-lysine from D-galactose as a chiral-precursor. |
| Q77892061 | Genetics of susceptibility to chronic experimental encephalomyelitis and arthritis |
| Q37172531 | HLA class II transgenic mice mimic human inflammatory diseases. |
| Q33815475 | HLA class II transgenic mice: models of the human CD4+ T-cell immune response. |
| Q34096264 | Human autoimmunity genes in mice |
| Q64228779 | Humanized Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Cell-Based Therapies |
| Q35754332 | Humanized animal models for autoimmune diseases |
| Q34731162 | Humanized mice as a model for rheumatoid arthritis |
| Q46439121 | Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis |
| Q38462400 | Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients |
| Q33840539 | Identification of HLA-class-II-restricted epitopes of autoantigens in transgenic mice |
| Q36456716 | Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice |
| Q24812914 | Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase |
| Q31076623 | Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background. |
| Q44563812 | Inhibition of T-cell activation with HLA-DR1/DR4 restricted Non-T-cell stimulating peptides |
| Q24792193 | Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8 |
| Q36430136 | MHC class II proteins and disease: a structural perspective |
| Q35620743 | Mice lacking all conventional MHC class II genes |
| Q63433140 | Mouse models for rheumatoid arthritis |
| Q45308833 | Prediction of collagen stability from amino acid sequence |
| Q31089923 | Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis |
| Q36735401 | Primer: comparative genetics of animal models of arthritis--a tool to resolve complexity |
| Q57536855 | Reply |
| Q24806869 | Rheumatoid arthritis viewed using a headache paradigm |
| Q79174581 | Single immunization of newborn mice with heterologous type-II collagen induces arthritic disease |
| Q27653688 | Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis |
| Q36526075 | Synthetic amino acid copolymers that bind to HLA-DR proteins and inhibit type II collagen-reactive T cell clones |
| Q73954901 | Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses |
| Q41856587 | T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic mice |
| Q24792514 | T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis |
| Q38477340 | Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases |
| Q52370705 | Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues. |
| Q73838437 | The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C |
| Q34351148 | The genetic and immunopathological processes underlying collagen-induced arthritis |
| Q24805318 | The genetics of rheumatoid arthritis and the need for animal models to find and understand the underlying genes |
| Q40443201 | The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation |
| Q24795875 | The relationship between predicted peptide-MHC class II affinity and T-cell activation in a HLA-DRbeta1*0401 transgenic mouse model |
| Q37181105 | The role of collagen antibodies in mediating arthritis |
| Q33713407 | Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis |
| Q34554029 | Transgenic models of autoimmune disease |
| Q33713326 | Transgenic mouse models of rheumatoid arthritis |
| Q35738486 | Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases |
Search more.